NCT05322941 - Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD) | Biotech Hunter

Enrollment

333

Participants

Timeline

Start Date

May 6, 2022

Primary Completion Date

April 11, 2024

Study Completion Date

July 22, 2024

Conditions

Marijuana Abuse

Interventions

DRUG

AEF0117

AEF0117 (1.0, 0.3, and 0.1 mg) capsules

DRUG

Placebo oral capsule

Corn oil capsule manufactured to mimic AEF0117 capsule

Trial Locations (11)

The Substance Treatment and Research Service (S.T.A.R.S.) of Columbia University/NYSPI., New York

Behavioral Clinical Research, Miami Lakes

Segal Trial, Lauderhill

Department of Psychiatry and Behavioral Sciences at UT Health San Antonio., San Antonio

CenExel CNR, Garden Grove

Cedar Clinical Research, Draper

Cedar clinical research, Phoenix

UCLA Department of Psychiatry and Biobehavioral Sciences, Los Angeles

CODA, Inc Research Department, Portland

Yale Stress Center - Addiction Program, New Haven

Addiction Sciences Division Department of Psychiatry and Behavioral Sciences Medical University of South Carolina, Charleston